These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 12417571)
1. Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. Behrens GM; Boerner AR; Weber K; van den Hoff J; Ockenga J; Brabant G; Schmidt RE J Clin Invest; 2002 Nov; 110(9):1319-27. PubMed ID: 12417571 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET. Sathekge M; Maes A; Kgomo M; Stolz A; Ankrah A; Van de Wiele C Nucl Med Commun; 2010 Apr; 31(4):311-4. PubMed ID: 20145581 [TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy. Haugaard SB; Andersen O; Madsbad S; Frøsig C; Iversen J; Nielsen JO; Wojtaszewski JF Diabetes; 2005 Dec; 54(12):3474-83. PubMed ID: 16306364 [TBL] [Abstract][Full Text] [Related]
4. Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. Haugaard SB; Andersen O; Dela F; Holst JJ; Storgaard H; Fenger M; Iversen J; Madsbad S Eur J Endocrinol; 2005 Jan; 152(1):103-12. PubMed ID: 15762193 [TBL] [Abstract][Full Text] [Related]
6. A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy. Blümer RM; van der Valk M; Ackermans M; Endert E; Serlie MJ; Reiss P; Sauerwein HP Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1097-104. PubMed ID: 19690066 [TBL] [Abstract][Full Text] [Related]
7. Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy. Blümer RM; van Vonderen MG; Sutinen J; Hassink E; Ackermans M; van Agtmael MA; Yki-Jarvinen H; Danner SA; Reiss P; Sauerwein HP AIDS; 2008 Jan; 22(2):227-36. PubMed ID: 18097225 [TBL] [Abstract][Full Text] [Related]
8. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance. Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310 [TBL] [Abstract][Full Text] [Related]
10. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Hadigan C; Kamin D; Liebau J; Mazza S; Barrow S; Torriani M; Rubin R; Weise S; Fischman A; Grinspoon S Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E289-98. PubMed ID: 16131513 [TBL] [Abstract][Full Text] [Related]
11. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. Paternostro G; Camici PG; Lammerstma AA; Marinho N; Baliga RR; Kooner JS; Radda GK; Ferrannini E J Clin Invest; 1996 Nov; 98(9):2094-9. PubMed ID: 8903329 [TBL] [Abstract][Full Text] [Related]
12. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases]. Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283 [TBL] [Abstract][Full Text] [Related]
13. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191 [TBL] [Abstract][Full Text] [Related]
15. Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. Williams KV; Bertoldo A; Mattioni B; Price JC; Cobelli C; Kelley DE J Clin Endocrinol Metab; 2003 Mar; 88(3):1271-9. PubMed ID: 12629118 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of lipolysis stimulates peripheral glucose uptake but has no effect on endogenous glucose production in HIV lipodystrophy. Lindegaard B; Frøsig C; Petersen AM; Plomgaard P; Ditlevsen S; Mittendorfer B; Van Hall G; Wojtaszewski JF; Pedersen BK Diabetes; 2007 Aug; 56(8):2070-7. PubMed ID: 17601993 [TBL] [Abstract][Full Text] [Related]
17. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987 [TBL] [Abstract][Full Text] [Related]
18. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356 [TBL] [Abstract][Full Text] [Related]
19. Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART. Haugaard SB; Andersen O; Madsbad S; Iversen J; Dela F J Infect; 2007 Jan; 54(1):89-97. PubMed ID: 16487595 [TBL] [Abstract][Full Text] [Related]
20. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]